Brain aging and Aβ₁₋₄₂ neurotoxicity converge via deterioration in autophagy-lysosomal system: a conditional Drosophila model linking Alzheimer's neurodegeneration with aging

Acta Neuropathol. 2011 Feb;121(2):183-91. doi: 10.1007/s00401-010-0772-0. Epub 2010 Nov 14.

Abstract

Aging is known to be the most prominent risk factor for Alzheimer's disease (AD); however, the underlying mechanism linking brain aging with AD pathogenesis remains unknown. The expression of human amyloid beta 42 peptide (Aβ₁₋₄₂), but not Aβ₁₋₄₀ in Drosophila brain induces an early onset and progressive autophagy-lysosomal neuropathology. Here we show that the natural process of brain aging also accompanies a chronic and late-onset deterioration of neuronal autophagy-lysosomal system. This process is characterized by accumulation of dysfunctional autophagy-lysosomal vesicles, a compromise of these vesicles leading to damage of intracellular membranes and organelles, necrotic-like intraneuronal destruction and neurodegeneration. In addition, conditional activation of neuronal autophagy in young animals is protective while late activation is deleterious for survival. Intriguingly, conditional Aβ₁₋₄₂ expression limited to young animals exacerbates the aging process to a greater extent than Aβ₁₋₄₂ expression in old animals. These data suggest that the neuronal autophagy-lysosomal system may shift from a functional and protective state to a pathological and deleterious state either during brain aging or via Aβ₁₋₄₂ neurotoxicity. A chronic deterioration of the neuronal autophagy-lysosomal system is likely to be a key event in transitioning from normal brain aging to pathological aging leading to Alzheimer's neurodegeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aging*
  • Alzheimer Disease / complications
  • Alzheimer Disease / genetics
  • Alzheimer Disease / pathology*
  • Amyloid beta-Peptides / genetics
  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Animals, Genetically Modified
  • Autophagy / drug effects*
  • Autophagy / physiology
  • Brain / metabolism
  • Brain / pathology*
  • Disease Models, Animal
  • Drosophila
  • Drosophila Proteins / genetics
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Green Fluorescent Proteins / genetics
  • Hormone Antagonists / administration & dosage
  • Humans
  • Lysosomes / drug effects
  • Lysosomes / metabolism*
  • Lysosomes / ultrastructure
  • Microscopy, Confocal / methods
  • Microscopy, Electron, Transmission / methods
  • Mifepristone / administration & dosage
  • Neurons / metabolism
  • Neurons / pathology
  • Neurons / ultrastructure
  • Peptide Fragments / genetics
  • Peptide Fragments / toxicity*

Substances

  • Amyloid beta-Peptides
  • Drosophila Proteins
  • Hormone Antagonists
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • Green Fluorescent Proteins
  • Mifepristone